Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

Clinical trial NCT05018013 · UNKNOWN

Trial details

NCT number: NCT05018013
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2021-08-21
Primary completion: 2022-08-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.